Table 2 Univariate and multivariate analysis of prognostic factors for overall survival in gastric cancer patients.
From: NKAIN1 expression relates to the immune evasion and prognosis of gastric cancer
Varible | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
HR | P >|z| | 95% CI | HR | P >|z| | 95% CI | |
NKAIN1 expression | ||||||
High vs. low and none | 1.848 | <0.001* | 1.319–2.590 | 1.618 | 0.006* | 1.150–2.276 |
Age (years) | ||||||
≤ 60 vs. > 60 | 1.156 | 0.420 | 0.813–1.644 | |||
Gender | ||||||
Male vs. Female | 1.062 | 0.752 | 0.733–1.538 | |||
Differentiation | ||||||
Well vs. Middle vs. Poor | 1.838 | 0.004* | 1.221–2.768 | 1.549 | 0.050 | 1.001–2.397 |
HER2 | ||||||
0 vs. 1 + vs. 2 + and 3+ | 1.283 | 0.059 | 0.991–1.660 | |||
T | ||||||
Tis and 1 vs. 2 vs. 3 vs. 4 | 2.005 | <0.001* | 1.635–2.459 | |||
N | ||||||
N0 vs. N1 vs. N2 vs. N3 | 2.021 | <0.001* | 1.719–2.376 | |||
M | ||||||
M0 vs. M1 | 4.035 | 0.001* | 1.775–9.173 | |||
TNM stage | ||||||
0 and I vs. II vs. III and IV | 2.693 | <0.001* | 2.068–3.508 | 2.320 | <0.001* | 1.728–3.115 |